Lab Grown Meat is Proving to be Worth Millions

Steakholder Foods (NASDAQ: STKH) sent shockwaves through the food technology space recently when they announced an agreement with the Gulf Cooperation Council, which represents the economic union between Kuwait, Qatar, Saudi Arabia and the UAE, amongst others.

The deal, which is worth multiple millions, is set to leverage the 3D printing technology of Steakholder Foods to produce structured foods and hybrid cultivated fish and meat.Why it matters:

  • One of the looming concerns about cultivated meat- also known as lab grown meat- is that it is not commercially viable or desirable to consume. This announcement is a strong signal to the contrary, which bodes well for the cell cultivated meat space as a whole
  • Steakholder Foods has seen investment from Ashton Kutcher and Guy O’Seary, amongst other notable venture capitalists, and this deal is important validation of Steakholder’s technology and science
  • Up until now, there has been very few commercial partnerships for cell cultivated meat announced, with most of the focus being in scientific research and development

The big picture:

  • Cell cultivated meat is currently only legal in two countries, Singapore and the United States
  • However that is quickly changing, with many countries announcing their intention to embrace cellular agriculture in a move towards carbon reduction and sustainability
  • While there are still some unknowns, it is becoming abundantly clear that cell cultivated meat is finally happening and is no longer a just a scientific concept

How does it work:

  • SteakHolder Foods has a proprietary 3D printing technology that enables the creation of structured foods and hybrid cultivated fish and meat.
  • Their 3D printing process pushes materials through a narrow nozzle, which enables the creation of fibre texture that best simulates the same fibres in animal derived meat
  • The entire process begins with the stem cells from a living animal going into a bioreactor, being turned into ‘bio-inks’ which are a combination of plant based and cell based ingredients and then placing those bio-inks into their 3D printer which manufactures a structured end product, which is ultimately identical to animal derived meat

Looking ahead:

  • This initial partnership announcement sets a precedent for future commercial deals that SteakHolder Foods may enter in to and validates their core technology
  • While cell cultivated meat is still in its infancy, there is clear evidence that there is a real demand on a global scale
  • SteakHolder Foods is uniquely positioned to be a leader in bioprinting and 3D printing technology for the cellular agriculture space as a whole, as they are currently one of the only companies globally who has an operational technology capable of producing structured meat products
The Summary: Steakholder Foods (NASDAQ: STKH) has secured a groundbreaking deal with the Gulf Cooperation Council to utilize their proprietary 3D printing technology for producing structured foods and hybrid cultivated fish and meat, challenging concerns about the viability of lab-grown meat. This move holds significant promise for the cell-cultivated meat sector, showing commercial interest growth in the emerging field and an important validation for the company's technology. This deal could be a sign of future potential for Steakholder Foods as more countries begin to prioritize food security and invest in cellular agriculture production facilities.

‍

Discover the world's most disruptive early stage companies with 40,000+ investors.

The markets and trends that matter, made simple.

Join top talent at the world's most respected institutions, companies, and venture capital funds.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Uncover the top stories and biggest trends in Food Tech.

Join The New Money's free newsletter to discover what's next from early stage public companies and startups in Food Tech and beyond.

Thanks for subscribing!
Keep an eye out for a welcome email shortly.
Click here to close this pop-up
Oops! Something went wrong while submitting the form.
Close

Disclaimer

The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by Steakholder Foods for a media campaign, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of Steakholder Foods without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.